Nurix Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Nurix Therapeutics, Inc. (NRIX) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Nov 2024Nov 2023Nov 2022Nov 2021Nov 2020
Current Assets
Cash and Cash Equivalents0.250.110.050.060.300.12
Short-Term Investments0.350.500.230.240.220.16
Cash & Short-Term Investments0.590.610.290.060.300.28
Accounts Receivable0.000.000.000.000.010.01
Inventory0.000.000.000.000.000.00
Other Current Assets0.010.010.010.240.010.01
Total Current Assets0.610.620.300.320.310.30
Non-Current Assets
Property, Plant & Equipment (Net)0.070.050.050.030.030.01
Long-Term Investments0.000.000.010.060.140.09
Other Non-Current Assets0.010.000.000.070.000.00
Total Non-Current Assets0.080.050.060.100.170.10
Total Assets0.690.670.360.420.480.40
Current Liabilities
Accounts Payable0.010.010.010.030.020.00
Short-Term Debt0.000.010.000.000.000.00
Accrued Liabilities0.030.020.020.010.000.01
Deferred Revenue0.020.040.050.040.040.03
Other Current Liabilities0.050.000.000.010.010.00
Total Current Liabilities0.090.100.090.070.070.04
Non-Current Liabilities
Long-Term Debt0.050.020.020.010.010.00
Other Non-Current Liabilities0.000.000.000.000.000.00
Total Non-Current Liabilities0.060.050.070.040.070.06
Total Liabilities0.150.140.160.110.130.11
Stockholders' Equity
Common Stock0.000.000.000.000.000.00
Retained Earnings-1.00-0.74-0.55-0.41-0.22-0.10
Accumulated Other Comprehensive Income0.000.000.000.000.000.00
Additional Paid-in Capital1.541.270.750.710.560.39
Shares Outstanding0.100.080.050.050.040.00
Total Stockholders' Equity0.540.530.200.300.340.29
Total Liabilities & Equity0.690.670.360.420.480.40